利柏特(605167.SH):子公司與拓烯光學簽訂重大合同
格隆匯1月15日丨利柏特(605167.SH)公佈,全資子公司上海利柏特工程技術有限公司於近日與浙江拓烯光學新材料有限公司(簡稱“拓烯光學”)簽訂了《7000噸/年SOOC項目總承包合同協議書》及《41000噸/年光學樹脂項目施工總承包合同》。合同一暫定合同價人民幣30,000萬元、合同二暫估合同價人民幣35,000萬元。
本合同的簽訂是公司與拓烯光學的再度合作,也是公司首次將模塊化的建設方式應用於高端光學新材料項目中,表明了拓烯光學對公司專業能力、服務水平和綜合實力的充分肯定與信任,體現了公司在模塊化建設及項目總承包領域的競爭優勢,有助於公司在高端光學新材料行業項目中模塊化建設經驗的積累。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.